nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—lung cancer	0.527	1	CbGaD
Trisalicylate-choline—PTGS2—Cisplatin—lung cancer	0.0875	0.356	CbGbCtD
Trisalicylate-choline—PTGS2—Etoposide—lung cancer	0.086	0.349	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—lung cancer	0.0726	0.295	CbGbCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—lung cancer	0.00099	0.365	CrCbGaD
Trisalicylate-choline—Magnesium salicylate—ALB—lung cancer	0.000882	0.325	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—lung cancer	0.000842	0.31	CrCbGaD
Trisalicylate-choline—Erythema multiforme—Gemcitabine—lung cancer	0.000432	0.00258	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Docetaxel—lung cancer	0.000428	0.00255	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vinblastine—lung cancer	0.000423	0.00252	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Methotrexate—lung cancer	0.000421	0.00251	CcSEcCtD
Trisalicylate-choline—Constipation—Vinblastine—lung cancer	0.000416	0.00248	CcSEcCtD
Trisalicylate-choline—Pain—Vinblastine—lung cancer	0.000416	0.00248	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Topotecan—lung cancer	0.000416	0.00248	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Erlotinib—lung cancer	0.000411	0.00245	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Topotecan—lung cancer	0.000411	0.00245	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Erlotinib—lung cancer	0.000406	0.00242	CcSEcCtD
Trisalicylate-choline—Vomiting—Teniposide—lung cancer	0.000405	0.00242	CcSEcCtD
Trisalicylate-choline—Pain—Topotecan—lung cancer	0.000404	0.00241	CcSEcCtD
Trisalicylate-choline—Constipation—Topotecan—lung cancer	0.000404	0.00241	CcSEcCtD
Trisalicylate-choline—Epistaxis—Paclitaxel—lung cancer	0.000402	0.0024	CcSEcCtD
Trisalicylate-choline—Rash—Teniposide—lung cancer	0.000402	0.0024	CcSEcCtD
Trisalicylate-choline—Dermatitis—Teniposide—lung cancer	0.000401	0.0024	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Vinblastine—lung cancer	0.000401	0.00239	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—lung cancer	0.000401	0.00239	CcSEcCtD
Trisalicylate-choline—Pain—Erlotinib—lung cancer	0.0004	0.00238	CcSEcCtD
Trisalicylate-choline—Constipation—Erlotinib—lung cancer	0.0004	0.00238	CcSEcCtD
Trisalicylate-choline—Headache—Teniposide—lung cancer	0.000399	0.00238	CcSEcCtD
Trisalicylate-choline—Erythema—Gemcitabine—lung cancer	0.000398	0.00237	CcSEcCtD
Trisalicylate-choline—Tinnitus—Cisplatin—lung cancer	0.000397	0.00237	CcSEcCtD
Trisalicylate-choline—Flushing—Cisplatin—lung cancer	0.000395	0.00236	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Topotecan—lung cancer	0.000389	0.00232	CcSEcCtD
Trisalicylate-choline—Anorexia—Vinorelbine—lung cancer	0.000385	0.0023	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—lung cancer	0.000385	0.0023	CcSEcCtD
Trisalicylate-choline—Nausea—Teniposide—lung cancer	0.000378	0.00226	CcSEcCtD
Trisalicylate-choline—Hypotension—Vinorelbine—lung cancer	0.000378	0.00225	CcSEcCtD
Trisalicylate-choline—Urticaria—Topotecan—lung cancer	0.000375	0.00224	CcSEcCtD
Trisalicylate-choline—Erythema—Cisplatin—lung cancer	0.000371	0.00221	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Etoposide—lung cancer	0.000369	0.0022	CcSEcCtD
Trisalicylate-choline—Weight increased—Docetaxel—lung cancer	0.000369	0.0022	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—lung cancer	0.000368	0.0022	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—lung cancer	0.000364	0.00217	CcSEcCtD
Trisalicylate-choline—Flushing—Etoposide—lung cancer	0.000362	0.00216	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Paclitaxel—lung cancer	0.000362	0.00216	CcSEcCtD
Trisalicylate-choline—Tinnitus—Paclitaxel—lung cancer	0.000357	0.00213	CcSEcCtD
Trisalicylate-choline—Flushing—Paclitaxel—lung cancer	0.000355	0.00212	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vinorelbine—lung cancer	0.000351	0.0021	CcSEcCtD
Trisalicylate-choline—Pain—Vinorelbine—lung cancer	0.000345	0.00206	CcSEcCtD
Trisalicylate-choline—Constipation—Vinorelbine—lung cancer	0.000345	0.00206	CcSEcCtD
Trisalicylate-choline—Lethargy—Methotrexate—lung cancer	0.000345	0.00206	CcSEcCtD
Trisalicylate-choline—Epistaxis—Docetaxel—lung cancer	0.000341	0.00203	CcSEcCtD
Trisalicylate-choline—Confusional state—Irinotecan—lung cancer	0.000336	0.002	CcSEcCtD
Trisalicylate-choline—Pruritus—Topotecan—lung cancer	0.000334	0.00199	CcSEcCtD
Trisalicylate-choline—Oedema—Irinotecan—lung cancer	0.000333	0.00199	CcSEcCtD
Trisalicylate-choline—Erythema—Paclitaxel—lung cancer	0.000333	0.00199	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Vinorelbine—lung cancer	0.000333	0.00199	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vinblastine—lung cancer	0.000333	0.00198	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Etoposide—lung cancer	0.000333	0.00198	CcSEcCtD
Trisalicylate-choline—Pruritus—Erlotinib—lung cancer	0.000331	0.00197	CcSEcCtD
Trisalicylate-choline—Shock—Irinotecan—lung cancer	0.000328	0.00196	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Paclitaxel—lung cancer	0.000326	0.00195	CcSEcCtD
Trisalicylate-choline—Oedema—Gemcitabine—lung cancer	0.000325	0.00194	CcSEcCtD
Trisalicylate-choline—Hepatitis—Docetaxel—lung cancer	0.000324	0.00193	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Topotecan—lung cancer	0.000323	0.00193	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Irinotecan—lung cancer	0.000322	0.00192	CcSEcCtD
Trisalicylate-choline—Dizziness—Vinblastine—lung cancer	0.000321	0.00192	CcSEcCtD
Trisalicylate-choline—Urticaria—Vinorelbine—lung cancer	0.000321	0.00192	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Erlotinib—lung cancer	0.00032	0.00191	CcSEcCtD
Trisalicylate-choline—Anorexia—Irinotecan—lung cancer	0.000318	0.0019	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Gemcitabine—lung cancer	0.000314	0.00187	CcSEcCtD
Trisalicylate-choline—Dizziness—Topotecan—lung cancer	0.000312	0.00186	CcSEcCtD
Trisalicylate-choline—Hypotension—Irinotecan—lung cancer	0.000311	0.00186	CcSEcCtD
Trisalicylate-choline—Anorexia—Gemcitabine—lung cancer	0.000309	0.00185	CcSEcCtD
Trisalicylate-choline—Vomiting—Vinblastine—lung cancer	0.000309	0.00184	CcSEcCtD
Trisalicylate-choline—Dizziness—Erlotinib—lung cancer	0.000309	0.00184	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Docetaxel—lung cancer	0.000307	0.00183	CcSEcCtD
Trisalicylate-choline—Headache—Vinblastine—lung cancer	0.000305	0.00182	CcSEcCtD
Trisalicylate-choline—Hypotension—Gemcitabine—lung cancer	0.000303	0.00181	CcSEcCtD
Trisalicylate-choline—Oedema—Cisplatin—lung cancer	0.000303	0.00181	CcSEcCtD
Trisalicylate-choline—Flushing—Docetaxel—lung cancer	0.000301	0.0018	CcSEcCtD
Trisalicylate-choline—Vomiting—Topotecan—lung cancer	0.0003	0.00179	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—lung cancer	0.000298	0.00178	CcSEcCtD
Trisalicylate-choline—Rash—Topotecan—lung cancer	0.000298	0.00178	CcSEcCtD
Trisalicylate-choline—Dermatitis—Topotecan—lung cancer	0.000298	0.00178	CcSEcCtD
Trisalicylate-choline—Vomiting—Erlotinib—lung cancer	0.000297	0.00177	CcSEcCtD
Trisalicylate-choline—Somnolence—Irinotecan—lung cancer	0.000296	0.00177	CcSEcCtD
Trisalicylate-choline—Headache—Topotecan—lung cancer	0.000296	0.00177	CcSEcCtD
Trisalicylate-choline—Rash—Erlotinib—lung cancer	0.000295	0.00176	CcSEcCtD
Trisalicylate-choline—Dermatitis—Erlotinib—lung cancer	0.000294	0.00176	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Irinotecan—lung cancer	0.000293	0.00175	CcSEcCtD
Trisalicylate-choline—Headache—Erlotinib—lung cancer	0.000293	0.00175	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Cisplatin—lung cancer	0.000292	0.00175	CcSEcCtD
Trisalicylate-choline—Asthma—Methotrexate—lung cancer	0.000292	0.00174	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Irinotecan—lung cancer	0.00029	0.00173	CcSEcCtD
Trisalicylate-choline—Nausea—Vinblastine—lung cancer	0.000289	0.00172	CcSEcCtD
Trisalicylate-choline—Somnolence—Gemcitabine—lung cancer	0.000289	0.00172	CcSEcCtD
Trisalicylate-choline—Anorexia—Cisplatin—lung cancer	0.000288	0.00172	CcSEcCtD
Trisalicylate-choline—Pruritus—Vinorelbine—lung cancer	0.000286	0.00171	CcSEcCtD
Trisalicylate-choline—Constipation—Irinotecan—lung cancer	0.000285	0.0017	CcSEcCtD
Trisalicylate-choline—Pain—Irinotecan—lung cancer	0.000285	0.0017	CcSEcCtD
Trisalicylate-choline—Hypotension—Cisplatin—lung cancer	0.000283	0.00169	CcSEcCtD
Trisalicylate-choline—Erythema—Docetaxel—lung cancer	0.000282	0.00168	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Gemcitabine—lung cancer	0.000282	0.00168	CcSEcCtD
Trisalicylate-choline—Nausea—Topotecan—lung cancer	0.000281	0.00167	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Methotrexate—lung cancer	0.00028	0.00167	CcSEcCtD
Trisalicylate-choline—Confusional state—Etoposide—lung cancer	0.000279	0.00167	CcSEcCtD
Trisalicylate-choline—Constipation—Gemcitabine—lung cancer	0.000278	0.00166	CcSEcCtD
Trisalicylate-choline—Pain—Gemcitabine—lung cancer	0.000278	0.00166	CcSEcCtD
Trisalicylate-choline—Nausea—Erlotinib—lung cancer	0.000278	0.00166	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vinorelbine—lung cancer	0.000276	0.00165	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Docetaxel—lung cancer	0.000276	0.00165	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Irinotecan—lung cancer	0.000275	0.00164	CcSEcCtD
Trisalicylate-choline—Confusional state—Paclitaxel—lung cancer	0.000274	0.00164	CcSEcCtD
Trisalicylate-choline—Oedema—Paclitaxel—lung cancer	0.000272	0.00162	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Etoposide—lung cancer	0.000268	0.0016	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Gemcitabine—lung cancer	0.000267	0.0016	CcSEcCtD
Trisalicylate-choline—Shock—Paclitaxel—lung cancer	0.000267	0.0016	CcSEcCtD
Trisalicylate-choline—Dizziness—Vinorelbine—lung cancer	0.000267	0.00159	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—lung cancer	0.000267	0.00159	CcSEcCtD
Trisalicylate-choline—Anorexia—Etoposide—lung cancer	0.000264	0.00158	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Cisplatin—lung cancer	0.000263	0.00157	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Paclitaxel—lung cancer	0.000263	0.00157	CcSEcCtD
Trisalicylate-choline—Drowsiness—Methotrexate—lung cancer	0.00026	0.00155	CcSEcCtD
Trisalicylate-choline—Anorexia—Paclitaxel—lung cancer	0.000259	0.00155	CcSEcCtD
Trisalicylate-choline—Hypotension—Etoposide—lung cancer	0.000259	0.00155	CcSEcCtD
Trisalicylate-choline—Pain—Cisplatin—lung cancer	0.000259	0.00154	CcSEcCtD
Trisalicylate-choline—Vomiting—Vinorelbine—lung cancer	0.000257	0.00153	CcSEcCtD
Trisalicylate-choline—Rash—Vinorelbine—lung cancer	0.000255	0.00152	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vinorelbine—lung cancer	0.000255	0.00152	CcSEcCtD
Trisalicylate-choline—Hypotension—Paclitaxel—lung cancer	0.000254	0.00152	CcSEcCtD
Trisalicylate-choline—Headache—Vinorelbine—lung cancer	0.000253	0.00151	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—lung cancer	0.000253	0.00151	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—lung cancer	0.00025	0.00149	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Cisplatin—lung cancer	0.000249	0.00149	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—lung cancer	0.000246	0.00147	CcSEcCtD
Trisalicylate-choline—Epistaxis—Methotrexate—lung cancer	0.000246	0.00147	CcSEcCtD
Trisalicylate-choline—Somnolence—Paclitaxel—lung cancer	0.000242	0.00144	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—lung cancer	0.000241	0.00144	CcSEcCtD
Trisalicylate-choline—Nausea—Vinorelbine—lung cancer	0.00024	0.00143	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Paclitaxel—lung cancer	0.000239	0.00143	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—lung cancer	0.000237	0.00141	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—lung cancer	0.000237	0.00141	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Paclitaxel—lung cancer	0.000236	0.00141	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—lung cancer	0.000234	0.00139	CcSEcCtD
Trisalicylate-choline—Constipation—Paclitaxel—lung cancer	0.000232	0.00139	CcSEcCtD
Trisalicylate-choline—Pain—Paclitaxel—lung cancer	0.000232	0.00139	CcSEcCtD
Trisalicylate-choline—Confusional state—Docetaxel—lung cancer	0.000232	0.00139	CcSEcCtD
Trisalicylate-choline—Oedema—Docetaxel—lung cancer	0.00023	0.00137	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—lung cancer	0.00023	0.00137	CcSEcCtD
Trisalicylate-choline—Pruritus—Gemcitabine—lung cancer	0.00023	0.00137	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—lung cancer	0.000228	0.00136	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Irinotecan—lung cancer	0.000228	0.00136	CcSEcCtD
Trisalicylate-choline—Shock—Docetaxel—lung cancer	0.000227	0.00135	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—lung cancer	0.000225	0.00134	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Paclitaxel—lung cancer	0.000224	0.00134	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gemcitabine—lung cancer	0.000222	0.00133	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—lung cancer	0.000221	0.00132	CcSEcCtD
Trisalicylate-choline—Dizziness—Irinotecan—lung cancer	0.00022	0.00131	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—lung cancer	0.00022	0.00131	CcSEcCtD
Trisalicylate-choline—Anorexia—Docetaxel—lung cancer	0.00022	0.00131	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—lung cancer	0.000218	0.0013	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—lung cancer	0.000216	0.00129	CcSEcCtD
Trisalicylate-choline—Urticaria—Paclitaxel—lung cancer	0.000216	0.00129	CcSEcCtD
Trisalicylate-choline—Hypotension—Docetaxel—lung cancer	0.000215	0.00128	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—lung cancer	0.000213	0.00127	CcSEcCtD
Trisalicylate-choline—Vomiting—Irinotecan—lung cancer	0.000212	0.00126	CcSEcCtD
Trisalicylate-choline—Rash—Irinotecan—lung cancer	0.00021	0.00125	CcSEcCtD
Trisalicylate-choline—Dermatitis—Irinotecan—lung cancer	0.00021	0.00125	CcSEcCtD
Trisalicylate-choline—Headache—Irinotecan—lung cancer	0.000209	0.00125	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Cisplatin—lung cancer	0.000207	0.00124	CcSEcCtD
Trisalicylate-choline—Vomiting—Gemcitabine—lung cancer	0.000206	0.00123	CcSEcCtD
Trisalicylate-choline—Somnolence—Docetaxel—lung cancer	0.000205	0.00122	CcSEcCtD
Trisalicylate-choline—Rash—Gemcitabine—lung cancer	0.000205	0.00122	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gemcitabine—lung cancer	0.000204	0.00122	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—lung cancer	0.000203	0.00121	CcSEcCtD
Trisalicylate-choline—Headache—Gemcitabine—lung cancer	0.000203	0.00121	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Docetaxel—lung cancer	0.000203	0.00121	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—lung cancer	0.000202	0.00121	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Docetaxel—lung cancer	0.0002	0.00119	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—lung cancer	0.000199	0.00119	CcSEcCtD
Trisalicylate-choline—Nausea—Irinotecan—lung cancer	0.000198	0.00118	CcSEcCtD
Trisalicylate-choline—Pain—Docetaxel—lung cancer	0.000197	0.00118	CcSEcCtD
Trisalicylate-choline—Constipation—Docetaxel—lung cancer	0.000197	0.00118	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—lung cancer	0.000196	0.00117	CcSEcCtD
Trisalicylate-choline—Nausea—Gemcitabine—lung cancer	0.000193	0.00115	CcSEcCtD
Trisalicylate-choline—Vomiting—Cisplatin—lung cancer	0.000192	0.00115	CcSEcCtD
Trisalicylate-choline—Pruritus—Paclitaxel—lung cancer	0.000192	0.00115	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—lung cancer	0.000191	0.00114	CcSEcCtD
Trisalicylate-choline—Rash—Cisplatin—lung cancer	0.000191	0.00114	CcSEcCtD
Trisalicylate-choline—Dermatitis—Cisplatin—lung cancer	0.000191	0.00114	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Docetaxel—lung cancer	0.00019	0.00113	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—lung cancer	0.00019	0.00113	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—lung cancer	0.000189	0.00113	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—lung cancer	0.000188	0.00112	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Paclitaxel—lung cancer	0.000186	0.00111	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—lung cancer	0.000183	0.00109	CcSEcCtD
Trisalicylate-choline—Dizziness—Paclitaxel—lung cancer	0.00018	0.00107	CcSEcCtD
Trisalicylate-choline—Nausea—Cisplatin—lung cancer	0.00018	0.00107	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—lung cancer	0.000176	0.00105	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—lung cancer	0.000176	0.00105	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—lung cancer	0.000175	0.00104	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—lung cancer	0.000175	0.00104	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—lung cancer	0.000174	0.00104	CcSEcCtD
Trisalicylate-choline—Vomiting—Paclitaxel—lung cancer	0.000173	0.00103	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—lung cancer	0.000172	0.00103	CcSEcCtD
Trisalicylate-choline—Rash—Paclitaxel—lung cancer	0.000171	0.00102	CcSEcCtD
Trisalicylate-choline—Dermatitis—Paclitaxel—lung cancer	0.000171	0.00102	CcSEcCtD
Trisalicylate-choline—Headache—Paclitaxel—lung cancer	0.00017	0.00102	CcSEcCtD
Trisalicylate-choline—Confusional state—Methotrexate—lung cancer	0.000167	0.000999	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—lung cancer	0.000165	0.000982	CcSEcCtD
Trisalicylate-choline—Pruritus—Docetaxel—lung cancer	0.000163	0.000972	CcSEcCtD
Trisalicylate-choline—Nausea—Paclitaxel—lung cancer	0.000161	0.000963	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—lung cancer	0.00016	0.000958	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—lung cancer	0.000158	0.000944	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Docetaxel—lung cancer	0.000158	0.00094	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—lung cancer	0.000155	0.000926	CcSEcCtD
Trisalicylate-choline—Dizziness—Docetaxel—lung cancer	0.000152	0.000909	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—lung cancer	0.000148	0.000881	CcSEcCtD
Trisalicylate-choline—Vomiting—Docetaxel—lung cancer	0.000146	0.000874	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—lung cancer	0.000146	0.000872	CcSEcCtD
Trisalicylate-choline—Rash—Docetaxel—lung cancer	0.000145	0.000867	CcSEcCtD
Trisalicylate-choline—Dermatitis—Docetaxel—lung cancer	0.000145	0.000866	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—lung cancer	0.000145	0.000865	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—lung cancer	0.000144	0.000861	CcSEcCtD
Trisalicylate-choline—Headache—Docetaxel—lung cancer	0.000144	0.000861	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—lung cancer	0.000144	0.000858	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—lung cancer	0.000142	0.000847	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—lung cancer	0.000141	0.000844	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—lung cancer	0.000139	0.000829	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—lung cancer	0.000137	0.000818	CcSEcCtD
Trisalicylate-choline—Nausea—Docetaxel—lung cancer	0.000137	0.000816	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—lung cancer	0.000137	0.000816	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—lung cancer	0.000134	0.000802	CcSEcCtD
Trisalicylate-choline—Urticaria—Methotrexate—lung cancer	0.000132	0.000787	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.00013	0.00229	CbGpPWpGaD
Trisalicylate-choline—Somnolence—Doxorubicin—lung cancer	0.000128	0.000763	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.000127	0.00224	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Doxorubicin—lung cancer	0.000127	0.000755	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—lung cancer	0.000125	0.000746	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—lung cancer	0.000123	0.000734	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—lung cancer	0.000123	0.000734	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000122	0.00216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—lung cancer	0.000122	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.00012	0.00212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.00012	0.00211	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—lung cancer	0.000118	0.000707	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—lung cancer	0.000118	0.00209	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Methotrexate—lung cancer	0.000117	0.000701	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—COL4A3BP—lung cancer	0.000116	0.00205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AZIN2—lung cancer	0.000116	0.00205	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Doxorubicin—lung cancer	0.000114	0.000681	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—lung cancer	0.000114	0.000678	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CD4—lung cancer	0.000111	0.00197	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Methotrexate—lung cancer	0.00011	0.000655	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000108	0.00191	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Methotrexate—lung cancer	0.000106	0.00063	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000105	0.00185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000105	0.00185	CbGpPWpGaD
Trisalicylate-choline—Rash—Methotrexate—lung cancer	0.000105	0.000625	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—lung cancer	0.000105	0.000624	CcSEcCtD
Trisalicylate-choline—Headache—Methotrexate—lung cancer	0.000104	0.000621	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000103	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—RB1—lung cancer	0.000103	0.00181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	0.000102	0.0018	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Doxorubicin—lung cancer	0.000102	0.000607	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CCND1—lung cancer	0.0001	0.00177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ATP5H—lung cancer	9.88e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—Nausea—Methotrexate—lung cancer	9.86e-05	0.000588	CcSEcCtD
Trisalicylate-choline—PTGS1—Biological oxidations—POMC—lung cancer	9.85e-05	0.00174	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Doxorubicin—lung cancer	9.84e-05	0.000587	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1A—lung cancer	9.67e-05	0.00171	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Doxorubicin—lung cancer	9.51e-05	0.000567	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	9.46e-05	0.00167	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AZIN2—lung cancer	9.22e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—COL4A3BP—lung cancer	9.22e-05	0.00163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—EP300—lung cancer	9.2e-05	0.00162	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Doxorubicin—lung cancer	9.14e-05	0.000545	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	9.08e-05	0.0016	CbGpPWpGaD
Trisalicylate-choline—Rash—Doxorubicin—lung cancer	9.06e-05	0.000541	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—lung cancer	9.06e-05	0.00054	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—lung cancer	9.01e-05	0.000537	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—PLBD1—lung cancer	8.81e-05	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	8.7e-05	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	8.66e-05	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	8.61e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	8.6e-05	0.00152	CbGpPWpGaD
Trisalicylate-choline—Nausea—Doxorubicin—lung cancer	8.54e-05	0.00051	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	8.33e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	8.18e-05	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD17B10—lung cancer	8.05e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MYC—lung cancer	8.02e-05	0.00142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ATP5H—lung cancer	7.84e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CASP3—lung cancer	7.82e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL2—lung cancer	7.81e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCND1—lung cancer	7.62e-05	0.00135	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	7.55e-05	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CKB—lung cancer	7.49e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	7.47e-05	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	7.41e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—lung cancer	7.39e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—lung cancer	7.32e-05	0.00129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	7.21e-05	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM2—lung cancer	7.04e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CNDP2—lung cancer	7.04e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	7.03e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	7e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLBD1—lung cancer	6.99e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.88e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTMR3—lung cancer	6.85e-05	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	6.68e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PGAM1—lung cancer	6.67e-05	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD17B10—lung cancer	6.39e-05	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2A7—lung cancer	6.37e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PGAM1—lung cancer	6.33e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	6.3e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	6.28e-05	0.00111	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SDC4—lung cancer	6.23e-05	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—lung cancer	6.11e-05	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—lung cancer	5.98e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.95e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CKB—lung cancer	5.94e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5.93e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SDC4—lung cancer	5.91e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	5.86e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	5.81e-05	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RRM1—lung cancer	5.67e-05	0.001	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA3—lung cancer	5.67e-05	0.001	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM2—lung cancer	5.59e-05	0.000987	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CNDP2—lung cancer	5.59e-05	0.000987	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTMR3—lung cancer	5.44e-05	0.00096	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—B4GALT5—lung cancer	5.33e-05	0.000942	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	5.32e-05	0.00094	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PGAM1—lung cancer	5.3e-05	0.000935	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SKI—lung cancer	5.21e-05	0.00092	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA4—lung cancer	5.19e-05	0.000916	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	5.18e-05	0.000915	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	5.17e-05	0.000913	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.07e-05	0.000896	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA2—lung cancer	5.06e-05	0.000893	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—B4GALT5—lung cancer	5.06e-05	0.000893	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2A7—lung cancer	5.05e-05	0.000892	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—lung cancer	5.02e-05	0.000886	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	5.01e-05	0.000885	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	5e-05	0.000883	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SDC4—lung cancer	4.95e-05	0.000873	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA1—lung cancer	4.88e-05	0.000862	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCC3—lung cancer	4.82e-05	0.000852	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.77e-05	0.000842	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C1—lung cancer	4.67e-05	0.000825	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.64e-05	0.000819	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—lung cancer	4.59e-05	0.000811	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UGT1A1—lung cancer	4.54e-05	0.000801	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PXN—lung cancer	4.52e-05	0.000799	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.52e-05	0.000798	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RRM1—lung cancer	4.5e-05	0.000795	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA3—lung cancer	4.5e-05	0.000795	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C1—lung cancer	4.43e-05	0.000782	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNG11—lung cancer	4.37e-05	0.000772	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.35e-05	0.000768	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	4.27e-05	0.000755	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—B4GALT5—lung cancer	4.24e-05	0.000748	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDOA—lung cancer	4.16e-05	0.000735	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	4.16e-05	0.000734	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA4—lung cancer	4.12e-05	0.000728	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NPPA—lung cancer	4.08e-05	0.00072	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	4.06e-05	0.000718	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA3—lung cancer	4.04e-05	0.000714	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.03e-05	0.000711	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA2—lung cancer	4.01e-05	0.000709	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPIA—lung cancer	3.98e-05	0.000703	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.97e-05	0.000702	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ALDOA—lung cancer	3.95e-05	0.000697	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADCY1—lung cancer	3.93e-05	0.000695	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG2—lung cancer	3.93e-05	0.000695	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA1—lung cancer	3.87e-05	0.000684	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO2—lung cancer	3.86e-05	0.000681	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HPGDS—lung cancer	3.86e-05	0.000681	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.84e-05	0.000678	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPP2R1B—lung cancer	3.83e-05	0.000677	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCC3—lung cancer	3.83e-05	0.000676	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.78e-05	0.000668	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—lung cancer	3.74e-05	0.000661	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADCY1—lung cancer	3.73e-05	0.000658	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C1—lung cancer	3.71e-05	0.000655	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2A6—lung cancer	3.7e-05	0.000653	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCLC—lung cancer	3.7e-05	0.000653	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.68e-05	0.00065	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO2—lung cancer	3.66e-05	0.000646	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP2R1B—lung cancer	3.63e-05	0.000642	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SMARCA4—lung cancer	3.63e-05	0.000642	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UGT1A1—lung cancer	3.6e-05	0.000636	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.53e-05	0.000623	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO1—lung cancer	3.51e-05	0.000619	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.49e-05	0.000617	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNG11—lung cancer	3.47e-05	0.000613	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.45e-05	0.00061	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.45e-05	0.000609	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.41e-05	0.000603	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO1—lung cancer	3.32e-05	0.000587	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDOA—lung cancer	3.31e-05	0.000584	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA3—lung cancer	3.21e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.15e-05	0.000557	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2E1—lung cancer	3.14e-05	0.000555	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG2—lung cancer	3.12e-05	0.000551	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADCY1—lung cancer	3.12e-05	0.000551	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NQO1—lung cancer	3.11e-05	0.000549	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APP—lung cancer	3.09e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF9—lung cancer	3.06e-05	0.000541	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HPGDS—lung cancer	3.06e-05	0.000541	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO2—lung cancer	3.06e-05	0.000541	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.04e-05	0.000538	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPP2R1B—lung cancer	3.04e-05	0.000537	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.02e-05	0.000533	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3e-05	0.00053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—lung cancer	2.97e-05	0.000524	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCLC—lung cancer	2.94e-05	0.000518	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2A6—lung cancer	2.94e-05	0.000518	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JUNB—lung cancer	2.93e-05	0.000517	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.92e-05	0.000516	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.88e-05	0.000509	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—STK11—lung cancer	2.8e-05	0.000495	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO1—lung cancer	2.78e-05	0.000491	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.77e-05	0.00049	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.74e-05	0.000483	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.63e-05	0.000465	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—lung cancer	2.59e-05	0.000458	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FOXO3—lung cancer	2.56e-05	0.000453	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAT—lung cancer	2.52e-05	0.000446	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.51e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2E1—lung cancer	2.5e-05	0.000441	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NQO1—lung cancer	2.47e-05	0.000436	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCB1—lung cancer	2.45e-05	0.000433	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.42e-05	0.000427	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TYMS—lung cancer	2.41e-05	0.000426	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—lung cancer	2.38e-05	0.000421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HES1—lung cancer	2.27e-05	0.000401	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A1—lung cancer	2.26e-05	0.000399	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ERCC2—lung cancer	2.24e-05	0.000396	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STK11—lung cancer	2.22e-05	0.000393	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERCC2—lung cancer	2.12e-05	0.000375	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.09e-05	0.000369	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB3—lung cancer	2.08e-05	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—lung cancer	2.06e-05	0.000364	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAT—lung cancer	2e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.99e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TERT—lung cancer	1.99e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCB1—lung cancer	1.95e-05	0.000344	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA1—lung cancer	1.94e-05	0.000342	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR1—lung cancer	1.93e-05	0.000341	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TYMS—lung cancer	1.91e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIF1A—lung cancer	1.9e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—lung cancer	1.89e-05	0.000334	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.86e-05	0.000328	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA1—lung cancer	1.84e-05	0.000324	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A1—lung cancer	1.79e-05	0.000317	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ERCC2—lung cancer	1.78e-05	0.000314	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—lung cancer	1.77e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—lung cancer	1.68e-05	0.000297	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—lung cancer	1.68e-05	0.000296	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KIT—lung cancer	1.68e-05	0.000296	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGF—lung cancer	1.66e-05	0.000293	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CREBBP—lung cancer	1.64e-05	0.00029	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BRAF—lung cancer	1.58e-05	0.000278	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6R—lung cancer	1.56e-05	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CD—lung cancer	1.56e-05	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CREBBP—lung cancer	1.55e-05	0.000275	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA1—lung cancer	1.54e-05	0.000272	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—lung cancer	1.54e-05	0.000271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAP2K1—lung cancer	1.48e-05	0.000262	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CD—lung cancer	1.47e-05	0.00026	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.47e-05	0.00026	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—lung cancer	1.4e-05	0.000248	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CB—lung cancer	1.36e-05	0.000239	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—lung cancer	1.34e-05	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—lung cancer	1.34e-05	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MDM2—lung cancer	1.32e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RAF1—lung cancer	1.32e-05	0.000232	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CREBBP—lung cancer	1.3e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB2—lung cancer	1.3e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTOR—lung cancer	1.29e-05	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CB—lung cancer	1.29e-05	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—lung cancer	1.28e-05	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CD—lung cancer	1.23e-05	0.000218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—lung cancer	1.22e-05	0.000215	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTEN—lung cancer	1.17e-05	0.000207	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—EP300—lung cancer	1.12e-05	0.000197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1A—lung cancer	1.11e-05	0.000197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTEN—lung cancer	1.11e-05	0.000196	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CB—lung cancer	1.08e-05	0.00019	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EP300—lung cancer	1.06e-05	0.000187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SRC—lung cancer	1.03e-05	0.000182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—lung cancer	9.93e-06	0.000175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NRAS—lung cancer	9.91e-06	0.000175	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—lung cancer	9.49e-06	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTEN—lung cancer	9.3e-06	0.000164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—lung cancer	9.23e-06	0.000163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—lung cancer	9.03e-06	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—EP300—lung cancer	8.87e-06	0.000157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—lung cancer	8.53e-06	0.000151	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—lung cancer	8.26e-06	0.000146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—lung cancer	7.83e-06	0.000138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HRAS—lung cancer	7.25e-06	0.000128	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—lung cancer	6.94e-06	0.000123	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—lung cancer	6.75e-06	0.000119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—lung cancer	6.56e-06	0.000116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—lung cancer	6.4e-06	0.000113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—lung cancer	5.36e-06	9.46e-05	CbGpPWpGaD
